Author:
Blair Hannah A.,Scott Lesley J.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. World Health Organization. Global tuberculosis report 2013. 2013. http://www.who.int/tb/publications/global_report/en/ . Accessed 7 Nov 2014.
2. Lange C, Abubakar I, Alffenaar JW, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014;44(1):23–63.
3. Zumla AI, Gillespie SH, Hoelscher M, et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis. 2014;14(4):327–40.
4. Brigden G, Nyang’wa B-T, du Cros P, et al. Principles for designing future regimens for multidrug-resistant tuberculosis. Bull World Health Organ. 2014;92(1):68–74.
5. European Medicines Agency. Delamanid assessment report. 2013. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002552/human_med_001699.jsp&mid=WC0b01ac058001d124 . Accessed 7 Nov 2014.
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献